From Rash to Refractory Diarrhea: Acute Graft-Versus-Host Disease After Living-Donor Liver Transplantation (ACG 2026) - Aug 29, 2026 - Abstract #P6317; Pres time: Oct 13, 2026; 10:30 AM - 04:00 PM; Location: Exhibit Halls A - D (Level 3); "Initial infectious evaluation was unrevealing except for low-level cytomegalovirus viremia, for which intravenous ganciclovir was started...High-dose methylprednisolone was initiated, but due to a lack of clinical improvement, ruxolitinib was added for steroid-refractory disease...E: Duodenal mucosa demonstrating crypt loss. F: Biopsy showing increased epithelial apoptosis."
Acute Graft versus Host Disease • Cytomegalovirus Infection • Fibrosis • Gastrointestinal Disorder • Graft versus Host Disease • Hematological Disorders • Hepatology • Immunology • Infectious Disease • Leukopenia • Metabolic Dysfunction-Associated Steatohepatitis • Transplantation
|
|
Spencer Rice MD 1; Skylar Hargrove MD 2; Vinay Jahagirdar MBBS 2; Bryce Hatfield MD 2; Hannah Lee MD 2; Stephen Bickston MD 2
|